Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
242.61
+0.64 (0.26%)
At close: Apr 24, 2025, 4:00 PM
244.01
+1.40 (0.58%)
After-hours: Apr 24, 2025, 7:54 PM EDT
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of $31.41 billion as of April 24, 2025. Its market cap has increased by 59.81% in one year.
Market Cap
31.41B
Enterprise Value
31.46B
1-Year Change
59.81%
Ranking
Category
Stock Price
$242.61
Market Cap Chart
Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $31.41B, an increase of 23,164.89%. That is a compound annual growth rate of 29.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2025 | 31.32B | 3.21% |
Dec 31, 2024 | 30.35B | 26.35% |
Dec 29, 2023 | 24.02B | -17.84% |
Dec 30, 2022 | 29.24B | 44.16% |
Dec 31, 2021 | 20.28B | 34.32% |
Dec 31, 2020 | 15.10B | 17.60% |
Dec 31, 2019 | 12.84B | 74.32% |
Dec 31, 2018 | 7.37B | -37.48% |
Dec 29, 2017 | 11.78B | 266.69% |
Dec 30, 2016 | 3.21B | -59.72% |
Dec 31, 2015 | 7.98B | 6.90% |
Dec 31, 2014 | 7.46B | 82.96% |
Dec 31, 2013 | 4.08B | 326.36% |
Dec 31, 2012 | 956.60M | 174.73% |
Dec 30, 2011 | 348.20M | -16.32% |
Dec 31, 2010 | 416.10M | -43.53% |
Dec 31, 2009 | 736.80M | -28.05% |
Dec 31, 2008 | 1.02B | -13.48% |
Dec 31, 2007 | 1.18B | 71.64% |
Dec 29, 2006 | 689.60M | 94.42% |
Dec 30, 2005 | 354.70M | 136.47% |
Dec 31, 2004 | 150.00M | 11.11% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 747.82B |
UnitedHealth Group | 388.99B |
Johnson & Johnson | 370.88B |
AbbVie | 312.74B |
Novo Nordisk | 276.62B |
Abbott Laboratories | 223.61B |
AstraZeneca | 213.42B |
Novartis AG | 208.99B |